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Hemophilia is an inherited coagulation disorder characterized by deficiency of the coagulation factor VIII or IX. 
When the management of hemostasis is inadequate, these patients are at high risk of experiencing intra and posto-
perative bleedings after tooth extractions. Coagulation factor replacement therapy allows performing most surgical 
procedures safely, although the factor levels and length of treatment have not been clearly determined. In this study, 
we present our experience in a retrospective series of 112 ambulatory tooth extractions under local anesthesia in 23 
patients with hemophilia using a coagulation factor replacement therapy in combination with tranexamic acid. The 
results obtained with this protocol were satisfactory and only one episode of mild postoperative bleeding occurred 
after seven days in a patient who did not have good treatment compliance.




Hemophilia is an inherited X chromosome-linked blee-
ding disorder characterized by deficiency of the coagu-
lation factor VIII (FVIII) or IX (FIX). It is estimated that 
it affects approximately 400,000 subjects worldwide (1). 
The deficiency of FVIII and FIX is called hemophilia A 
(HA) and hemophilia B (HB) respectively.  Eighty per-
cent have type A (2). Depending on the FVIII or FIX 
activity, it may be classified in: severe (< 1%), mode-
rate (1-5%) and mild (> 5 and < 40% of normal) (3). 
The main characteristic of hemophilia is a tendency to 
bleeding and, consequently, these patients are at risk of 
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experiencing intra and postoperative bleeding episodes 
after oral surgery procedures. The World Federation of 
Hemophilia recommends treating the factor deficiency 
with the specific concentrate, whenever possible, and 
that the factor levels be returned to normal prior to per-
forming any invasive procedure. In addition to factor re-
placement therapy, the World Federation of Hemophilia 
recommends the use of tranexamic acid as an effective 
means for clot stabilization (2). In this article, we pre-
sent our experience in a retrospective series of 112 tooth 
extractions using factor replacement therapy in combi-
nation with tranexamic acid.  
 
Case Report
Patients over 18 years old with diagnosed HA and HB 
who underwent tooth extractions at our facility from 
June 2012 to June 2017 were included.  Routine preope-
rative tests including factor VIII/ IX dosage and scree-
ning tests and inhibitor assays were carried out. All the 
procedures were carried out by the same surgical team 
on an outpatient basis, in a hospital setting and under lo-
cal anesthesia. Factor VIII (ADVATE®, Koate®, Koge-
nate®, Xyntha®) or IX concentrates (Berinin®, Inmu-
nine) were administered approximately thirty minutes 
before the anesthetic infiltration in order to maintain the 
factor levels above 60%. 
To calculate the factor VIII preoperative dose in pa-
tients with hemophilia A, the following formula was 
used: Dose (IU)= body surface (kg) x level of desired 
factor VIII increase (IU/dL) x 0.5. In patients with HB, 
the preoperative factor IX dose was calculated using the 
following formula: Dose (IU)= body surface (kg) x le-
vel of desired factor IX increase (IU/dL) x 0.5. In ad-
dition, one gram of tranexamic acid was intravenously 
administered. Local anesthesia with articaine 4% with 
epinephrine 1:100,000 (Totalcaína Forte, Laboratorios 
Bernabó, Buenos Aires, Argentina) was administered. 
Absorbable 3.0 sutures (Vicryl, Ethicon Inc., USA) were 
used in all cases. No local hemostatic agents were used. 
After surgery, subsequent doses of factor VIII or IX 
were administered for 72 hours calculated on the indivi-
dual patient’s pharmacokinetics in order to maintain the 
factor levels above 30% during the postoperative period 
and 2 grams of tranexamic acid orally every 6/8 hours 
for 72 hours. In all the cases, antibiotic prophylaxis with 
2 grams of amoxicillin (Amixen, Laboratorios Bernabó, 
Buenos Aires, Argentina), orally, one hour prior to the 
surgical procedure, was indicated. In those cases of acu-
te infection, antibiotic therapy was maintained until the 
infection resolved. Analgesic therapy with paracetamol 
1 gram (Laboratorios Raffo, Buenos Aires, Argentina), 
orally, was indicated every eight hours. In cases of mo-
derate to severe pain, tramadol 50 milligrams (Calma-
dor 50 mg, Laboratorios Finadiet, Argentina), orally, 
was indicated every eight hours. All the patients were 
discharged prior to the 24 hour period and checkups at 
the Outpatient Clinics every 24 hours were indicated for 
three days. They were scheduled for a new checkup se-
ven days later. Indications included: no smoking, avoi-
ding hot food and beverages until sensation in mouth 
has been recovered, not using mouthwash for 48 hours, 
applying cold locally and avoiding physical activity un-
til the checkup visit was completed on the seventh day. 
The main findings are listed in table 1, 1 continue. Two 
hundred and twelve tooth extractions were carried out in 
23 patients. The mean age was 43 years old (18-65 years 
old range). All the patients were males. Thirty surgical 
procedures were carried out. Nineteen patients (83%) 
had HA, three patients (13%) had HB and one patient 
(4%) had HA and Von Willebrand disease. Eighty-nine 
percent of the patients with HA and 100% of the patients 
with HB had severe hemophilia. None of the patients 
developed inhibitors. In patients with HA, the mean ba-
seline factor concentration was 5.2% (standard deviation 
= 6.27%) and 4.4% (standard deviation = 2.95%) in pa-
tients with HB. Chart one shows the factor levels after 
concentrate administration. No intraoperative complica-
tions occurred. On the seventh day, a postoperative mi-
nor bleeding occurred in a patient with severe HB (4%) 
who did not attend the postoperative checkups for factor 
administration. Bleeding was controlled by local hemos-
tasis maneuvers using gauzes soaked in tranexamic acid 




Patients with hemophilia are at risk of experiencing intra 
and postoperative bleeding after oral surgery procedures; 
consequently, these should be carried out at specialized 
centers in collaboration with Hematologists with expe-
rience in managing this disease (4). The World Federa-
tion of Hemophilia recommends treating the factor defi-
ciency with the specific concentrate, whenever possible, 
and that the factor levels be returned to normal prior to 
performing any invasive procedure. In this paper, we 
describe the results obtained in a series of 23 patients 
who underwent 30 minor oral surgical procedures using 
a factor replacement therapy in combination with trane-
xamic acid protocol. A mild case of bleeding occurred 
in a patient who did not have good compliance with the 
postoperative instructions. In our series, there were no 
cases of postoperative infection. The results obtained in 
our series were similar to those reported by other authors 
(4-14). At present, the coagulation factor concentrates 
undergo viral inactivation and consequently the most 
severe complication related to the hemophilia treatment 
is developing anti-FVIII and FIX inhibitors (2). The in-
cidence of inhibitor development in patients with severe 
hemophilia A is of approximately 30% and of 2-4% in 
patients with severe hemophilia B (14). Inhibitors were 
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not detected in any of the patients included in our series. 
The mean baseline factor concentration was 5.2% in pa-
tients with HA (standard deviation= 6.27%) and 4.4% 
(standard deviation= 2.95%) in patients with HB. These 
apparently high values can be explained by the fact that 
some of these patients were under prophylaxis with coa-
gulation factors when the tests were carried out. 
Our protocol includes tranexamic acid administration 
as coadjuvant agent in combination with factor repla-
cement therapy. In 2015, Watterson et al. published a 
systematic review on the use of adjuvant therapy with 
antifibrinolytics in oral surgery procedures in patients 
with hereditary coagulation disorders. Although the qua-
lity of the evidence available is low, there seems to be a 
benefit in reducing bleeding with no significant increase 
in adverse effects (15). 
Thirty tooth extraction procedures were carried out and 
one postoperative episode of bleeding occurred. The re-
sults obtained in our series by using this protocol were 
satisfactory, although compliance with treatment and 
especially with postoperative checkups is something to 
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